Maintaining Quality of Care GU Cancer Treatment During the Plateau Phase of COVID-19 in British Columbia - Kim Chi
Kim Chi
Recorded Date: April 29, 2020Joining Alicia Morgans from Vancouver, Canada is Kim Chi discussing how his practice is now looking forward during the plateau phase of the COVID-19 pandemic.
FDA Approves First PARP Inhibitor Rucaparib for Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Charles Ryan
Charles Ryan
Alicia Morgans and Charles Ryan highlight the breaking news that the Food and Drug Administration (FDA) approved the first PARP Inhibitor for men with metastatic castration-resistant prostate cancer (mCRPC) and a deleterious BRCA mutation.